New Medical Devices Regulation & Risk Management

March 15, 2017

The revised Medical Devices Regulation (MDR) will change the regulatory environment of medical devices in Europe to a more stringent one.

Compared to the MDD, the MDR promotes a life-cycle approach similar to what the US FDA and many international standards advocate.

MDR highlights the importance of medical device risk management. Although risk management has been a requirement also in the MDD, it has never before been stated in such clear terms:

“/…/ in order to minimize risks or prevent incidents related to medical devices, manufacturers should establish a system for risk management and a system for reporting of incidents and field safety corrective actions./…/”

Annex I of the new MDR goes significantly into more details than the current MDDs:

“/…/ In carrying out risk management manufacturers shall:

(a) establish and document a risk management plan for each device;

(b) identify and analyse the known and foreseeable hazards associated with each device;

(c) estimate and evaluate the risks associated with, and occurring during, the intended use and during reasonably foreseeable misuse;

(d) eliminate or control the risks referred to in point (c) in accordance with the requirements of Section 4;

(e) evaluate the impact of information from the production phase and, in particular, from the post-market surveillance system, on hazards and the frequency of occurrence thereof, on estimates of their associated risks, as well as on the overall risk, benefit-risk ratio and risk acceptability; and

(f) based on the evaluation of the impact of the information referred to in point (e), if necessary amend control measures in line with the requirements of Section 4. /…/”

These requirements are in line with ISO 14971, so they should not catch anyone by surprise.

The new regulation will apply three years after its formal publication, becoming mandatory by most likely early 2020. For Quality Management System regulation, the ISO 13485 that was released in 2016 will replace the earlier versions and become mandatory in early 2019.

For more information about medical device risk management system in Atlassian JIRA – SoftComply Risk Manager

Table of Contents

Ready to get started?

Contact us to book a demo and learn how SoftComply can cover all your needs

6 Steps to Agile Risk Management in Jira
Picture of Marion Lepmets

Marion Lepmets

CEO
June 19, 2025

Balancing agile development with regulatory compliance feels like trying to mix oil and water. But what if I told you there’s a way to integrate risk management directly into your Jira workflow without sacrificing speed or compliance?  Based on a recent webinar with Aaron Morris, I’ve distilled the process into...

Solution Partners to verticals and business users
Picture of Marion Lepmets

Marion Lepmets

CEO
June 11, 2025

For years, Atlassian solution partners have built successful businesses around helping IT teams configure Jira and Confluence, manage licenses, and handle technical implementations. But that world is rapidly changing. Atlassian is shifting its focus from IT admins to business users in specific departments and industries – and partners who don’t...

Agile
Picture of Monika Isak

Monika Isak

Head of Growth
June 2, 2025

For regulated industries – such as Pharma, MedTech, FinTech and Aviation – compliance isn’t optional; it’s mandatory. Tools like Jira and Confluence are powerful, but their true potential is only realized when configured to meet industry-specific regulatory requirements. This is where industry consultants come into play, offering expertise that goes...